Search results
Mesoblast (MESO) Soars 208% YTD on Positive Regulatory Updates
Zacks via Yahoo News· 6 days agoJakafi is a first-in-class JAK1/JAK2 inhibitor. INCY has a collaboration agreement with the Swiss...
Jakafi is a first-in-class JAK1/JAK2 inhibitor. INCY has a collaboration agreement with the Swiss...